dc.contributor.author |
Meier, Friedegund |
|
dc.date.accessioned |
2017-07-06T16:47:24Z |
|
dc.date.available |
2017-07-06T16:47:24Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
2162-402X |
|
dc.identifier.uri |
http://hdl.handle.net/10900/76880 |
|
dc.language.iso |
en |
en |
dc.publisher |
Taylor & Francis Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1080/2162402X.2015.1101207 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.title |
Vemurafenib and ipilimumab: A promising combination? Results of a case series |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20160915142648_02162 |
|
utue.personen.roh |
Hassel, Jessica C. |
|
utue.personen.roh |
Lee, Sophia B. |
|
utue.personen.roh |
Meiss, Frank |
|
utue.personen.roh |
Meier, Friedegund |
|
utue.personen.roh |
Dimitrakopoulou-Strauss, Antonia |
|
utue.personen.roh |
Jaeger, Dirk |
|
utue.personen.roh |
Enk, Alexander H. |
|
dcterms.isPartOf.ZSTitelID |
Oncoimmunology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article e1101207 |
de_DE |
dcterms.isPartOf.ZS-Volume |
5 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
|